I think that if you are looking at long term buy and hold, stocks from the core are better candidates, from these two, however, JCOM has probably the higher potential. None of my OB hit, but the second LEXR got sold for $.70 ($21.10) and AMGN for the bucker at $60.25.
They both are a POS. should have kept my short on both of them.But hey remember last month they both appeared to have curred cancer, now NVEC must have discoverd the cure.